ContextVision Launches New Generation of Products for 3D Ultrasound and Mammography at RSNA 2014

STOCKHOLM, Nov. 24, 2014 /PRNewswire/ -- At the upcoming 100^th Scientific Assembly and Annual Meeting of RSNA, ContextVision, will launch a new groundbreaking product range for 3D ultrasound. The new second generation of 3D volume processing and the photo-like 3D rendering software provides new features that brings 3D imaging to a higher level. The products offer a higher diagnostic value and support further use of 3D ultrasound.

GOPiCE® 2.0 is the only product on the market for real-time volumetric image processing for 3D ultrasound images. The new product includes several new features, enabling optimization for different visualization techniques, both MPR view and rendered view. The intelligent processing within near- and far-field guarantees excellent image quality throughout the whole volume.

Additionally, ContextVision will, for the first time, show a completely new feature within the new innovative 3D visualization product, REALiCE^TM. This new feature, the Skeletal View, provides excellent visualization of the fetal skeleton and helps review details related to bone mineralization and physical defects.

REALiCE is a versatile visualization software which delivers photo-like images and supports early fetal diagnosis. By combining the GOPiCE adaptive 3D/4D volume enhancement with new true-to-data rendering technology, it provides ultrasound manufacturers with superb high-end visualization capabilities and image quality.

ContextVision set the 3D/4D ultrasound application trend in 2009 when it released GOPiCE® US, the first product to filter 3D/4D ultrasound images. ContextVision continues to lead ultrasound imaging by providing OEMs with the best ultrasound image quality available for not only OB/GYN, but general imaging.

"REALiCE provides superior visualization of subtle fetal brain defects and other fetal anomalies. Standard fetus measurements, such as fetal abdominal diameter, abdominal circumference and femur length, become more accurate due to clearer imaging," said Ph.D. Anders Selbing, professor emeritus at Karolinska University Hospital.

As for mammography, the newly released GOPView® Mammo3 will be featured at ContextVision's booth. GOPView Mammo3 is a complete image processing software for screening as well as for diagnostic digital mammography. It is adaptable for the entire range of mammography systems and provides optimized images for different breast densities, as well as customized for regional and individual preferences.

"ContextVision continues to develop gold standard products," shared Anita Tollstadius, ContextVision CEO. "I am particularly proud of the new 3D products that will change the way we visualize 3D and 4D images. This year we're taking an even greater lead in this growing market segment with 3D/4D ultrasound."

For demonstrations of ContextVision's GOPiCE 2.0, REALiCE, GOPView Mammo3 and software for XR, MRI and CT, visit booth #7210 in North Building, Hall B at RSNA. To learn more about ContextVision's collection of image enhancement software, visit www.contextvision.com.

About ContextVision
ContextVision's technology provides doctors with improved images, which are crucial for accurate diagnosis and treatment. ContextVision is the industry leader in medical image analysis and enhancement software, with more than 150,000 installations worldwide through its OEM customers. The company started out as an industry pioneer more than 30 years ago, and is today developing the next generation of medical imaging software for 2D/3D/4D ultrasound, MRI, X-Ray, mammography and CT. ContextVision is based in Sweden and listed on the Oslo Stock Exchange under the ticker COV. For more information, please visit www.contextvision.com.

SOURCE ContextVision